Tsai G - Search Results

1

D-serine added to antipsychotics for the treatment of schizophrenia.

Tsai G, Yang P, Chung LC, Lange N, Coyle JT. Tsai G, et al. Biol Psychiatry. 1998 Dec 1;44(11):1081-9. doi: 10.1016/s0006-3223(98)00279-0. Biol Psychiatry. 1998. PMID: 9836012 Clinical Trial.

2

D-alanine added to antipsychotics for the treatment of schizophrenia.

Tsai GE, Yang P, Chang YC, Chong MY. Tsai GE, et al. Biol Psychiatry. 2006 Feb 1;59(3):230-4. doi: 10.1016/j.biopsych.2005.06.032. Epub 2005 Sep 9. Biol Psychiatry. 2006. PMID: 16154544 Clinical Trial.

3

Glutamatergic mechanisms in schizophrenia.

Tsai G, Coyle JT. Tsai G, et al. Annu Rev Pharmacol Toxicol. 2002;42:165-79. doi: 10.1146/annurev.pharmtox.42.082701.160735. Annu Rev Pharmacol Toxicol. 2002. PMID: 11807169 Review.

4

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.

Tsai G, Lane HY, Yang P, Chong MY, Lange N. Tsai G, et al. Biol Psychiatry. 2004 Mar 1;55(5):452-6. doi: 10.1016/j.biopsych.2003.09.012. Biol Psychiatry. 2004. PMID: 15023571 Clinical Trial.

5

Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.

Tsai GE, Falk WE, Gunther J, Coyle JT. Tsai GE, et al. Am J Psychiatry. 1999 Mar;156(3):467-9. doi: 10.1176/ajp.156.3.467. Am J Psychiatry. 1999. PMID: 10080566 Clinical Trial.

6

D-serine added to clozapine for the treatment of schizophrenia.

Tsai GE, Yang P, Chung LC, Tsai IC, Tsai CW, Coyle JT. Tsai GE, et al. Among authors: tsai ic, tsai cw. Am J Psychiatry. 1999 Nov;156(11):1822-5. doi: 10.1176/ajp.156.11.1822. Am J Psychiatry. 1999. PMID: 10553752 Clinical Trial.

7

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

Goff DC, Tsai G, Manoach DS, Coyle JT. Goff DC, et al. Among authors: tsai g. Am J Psychiatry. 1995 Aug;152(8):1213-5. doi: 10.1176/ajp.152.8.1213. Am J Psychiatry. 1995. PMID: 7625475 Clinical Trial.

8

D-cycloserine added to clozapine for patients with schizophrenia.

Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT. Goff DC, et al. Among authors: tsai g. Am J Psychiatry. 1996 Dec;153(12):1628-30. doi: 10.1176/ajp.153.12.1628. Am J Psychiatry. 1996. PMID: 8942463 Clinical Trial.

9

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Tsai G, et al. Am J Psychiatry. 1998 Sep;155(9):1207-13. doi: 10.1176/ajp.155.9.1207. Am J Psychiatry. 1998. PMID: 9734544

10

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.

Tsai G, van Kammen DP, Chen S, Kelley ME, Grier A, Coyle JT. Tsai G, et al. Biol Psychiatry. 1998 Oct 15;44(8):667-74. doi: 10.1016/s0006-3223(98)00151-6. Biol Psychiatry. 1998. PMID: 9798069 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters